Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor

Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor

User Photo
Annual-Meeting

2 years
50 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor at Annual Meeting 2018
Up Next Autoplay